loadpatents
Patent applications and USPTO patent grants for Singh; Kumar Kamlesh.The latest application filed is for "process for preparation of midodrine and intermediates thereof".
Patent | Date |
---|---|
Process For Preparation Of Midodrine And Intermediates Thereof App 20220144754 - Singh; Kumar Kamlesh ;   et al. | 2022-05-12 |
Process For Preparation Of Isoxazoline Substituted Benzamide Compound App 20220064130 - SINGH; Kumar Kamlesh ;   et al. | 2022-03-03 |
Process for preparation of grapiprant Grant 11,254,675 - Singh , et al. February 22, 2 | 2022-02-22 |
Composition Comprising High Purity Pyrrole Derivative And Method For Preparation Thereof App 20220023262 - SINGH; Kumar Kamlesh ;   et al. | 2022-01-27 |
Process For Preparation Of Grapiprant App 20210347776 - SINGH; Kumar Kamlesh ;   et al. | 2021-11-11 |
Process For Preparation Of Fosnetupitant App 20210214306 - SINGH; Kumar Kamlesh ;   et al. | 2021-07-15 |
Process For Preparation Of Grapiprant App 20210079000 - SINGH; Kumar Kamlesh ;   et al. | 2021-03-18 |
Process for preparation of apalutamide Grant 10,934,269 - Singh , et al. March 2, 2 | 2021-03-02 |
Amorphous Ertugliflozin And Process For Its Preparation App 20200376017 - DESAI; Sanjay Jagdish ;   et al. | 2020-12-03 |
Process for preparation of apalutamide Grant 10,807,965 - Singh , et al. October 20, 2 | 2020-10-20 |
A Process For Preparation Of Triaminopyrimidine Compound And Intermediates Thereof App 20200207738 - SINGH; Kumar Kamlesh ;   et al. | 2020-07-02 |
Process For Preparation Of Apalutamide App 20200071287 - SINGH; Kumar Kamlesh ;   et al. | 2020-03-05 |
Process For Preparation Of Apalutamide App 20200024250 - SINGH; Kumar Kamlesh ;   et al. | 2020-01-23 |
Amorphous vortioxetine and salts thereof Grant 10,414,741 - Dwivedi , et al. Sept | 2019-09-17 |
Crystalline form of rifaximin and process for its preparation Grant 9,988,398 - Singh , et al. June 5, 2 | 2018-06-05 |
Amorphous form of linagliptin and process for preparation thereof Grant 9,879,011 - Dwivedi , et al. January 30, 2 | 2018-01-30 |
Novel Crystalline Form Of Rifaximin And Process For Its Preparation App 20170349608 - SINGH; Kumar Kamlesh ;   et al. | 2017-12-07 |
Process For Preparation Of Androgen Receptor Antagonist App 20170158643 - Dwivedi; Shri Prakash Dhar ;   et al. | 2017-06-08 |
Process for preparation of androgen receptor antagonist Grant 9,611,225 - Dwivedi , et al. April 4, 2 | 2017-04-04 |
Process for the preparation of apixaban Grant 9,603,846 - Khera , et al. March 28, 2 | 2017-03-28 |
Process for the preparation of amorphous imatinib mesylate Grant 9,439,903 - Dwivedi , et al. September 13, 2 | 2016-09-13 |
Process for the preparation of sitagliptin phosphate Grant 9,409,912 - Dwivedi , et al. August 9, 2 | 2016-08-09 |
An Amorphous Vortioxetine And Salts Thereof App 20160214949 - DWIVEDI; Shri Prakash Dhar ;   et al. | 2016-07-28 |
Amorphous form of apremilast Grant 9,351,957 - Khera , et al. May 31, 2 | 2016-05-31 |
Process For The Preparation Of Apixaban App 20160143894 - KHERA; Brij ;   et al. | 2016-05-26 |
An Improved Process For The Preparation Of Apixaban And Intermediates Thereof App 20160113912 - DWIVEDI; Shriprakash Dhar ;   et al. | 2016-04-28 |
Process for preparation of amorphous form of dasatinib Grant 9,249,134 - Dwivedi , et al. February 2, 2 | 2016-02-02 |
Amorphous Form Of Apremilast App 20150283249 - KHERA; Brij ;   et al. | 2015-10-08 |
Process For Preparation Of Androgen Receptor Antagonist App 20150210649 - Dwivedi; Shri Prakash Dhar ;   et al. | 2015-07-30 |
Process For The Preparation Of Sitagliptin Phosphate App 20150087834 - DWIVEDI; Shri prakash Dhar ;   et al. | 2015-03-26 |
Amorphous Form Of Linagliptin And Process For Preparation Thereof App 20150051228 - Dwivedi; Shriprakash Dhar ;   et al. | 2015-02-19 |
Process For Preparation Of Amorphous Form Of Dasatinib App 20140343073 - DWIVEDI; SHRIPRAKASH DHAR ;   et al. | 2014-11-20 |
Process For The Preparation Of Amorphous Imatinib Mesylate App 20140121215 - DWIVEDI; Shriprakash Dhar ;   et al. | 2014-05-01 |
Process For The Preparation And Purification Of Azilsartan Medoxomil App 20140113942 - DWIVEDI; Shriprakash Dhar ;   et al. | 2014-04-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.